As of close of business last night, Danimer Scientific Inc’s stock clocked out at $1.05, down -1.87% from its previous closing price of $1.07. In other words, the price has decreased by -$0.0200 from its previous closing price. On the day, 528796 shares were traded.
Ratios:
To gain a deeper understanding of DNMR’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.26 and its Current Ratio is at 6.87. In the meantime, Its Debt-to-Equity ratio is 1.47 whereas as Long-Term Debt/Eq ratio is at 1.45.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on October 12, 2022, initiated with a Overweight rating and assigned the stock a target price of $4.50.
On September 23, 2021, Cowen started tracking the stock assigning a Outperform rating and target price of $21.
On January 06, 2021, Jefferies started tracking the stock assigning a Buy rating and target price of $31.Jefferies initiated its Buy rating on January 06, 2021, with a $31 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 28 ’23 when HENDRIX RICHARD J bought 50,000 shares for $0.94 per share. The transaction valued at 46,915 led to the insider holds 50,000 shares of the business.
HENDRIX RICHARD J bought 50,000 shares of DNMR for $46,480 on Nov 28 ’23. The Director now owns 391,324 shares after completing the transaction at $0.93 per share. On Jun 20 ’23, another insider, Tuten Scott, who serves as the Chief Marketing Officer of the company, sold 10,000 shares for $2.74 each. As a result, the insider received 27,390 and left with 346,478 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNMR now has a Market Capitalization of 119.95M and an Enterprise Value of 468.85M. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.57 while its Price-to-Book (P/B) ratio in mrq is 0.39. Its current Enterprise Value per Revenue stands at 10.04 whereas that against EBITDA is -4.88.
Stock Price History:
Over the past 52 weeks, DNMR has reached a high of $4.45, while it has fallen to a 52-week low of $0.60. The 50-Day Moving Average of the stock is 1.0988, while the 200-Day Moving Average is calculated to be 1.5818.
Shares Statistics:
It appears that DNMR traded 1.00M shares on average per day over the past three months and 710.77k shares per day over the past ten days. A total of 102.83M shares are outstanding, with a floating share count of 100.22M. Insiders hold about 12.27% of the company’s shares, while institutions hold 30.84% stake in the company. Shares short for DNMR as of Mar 15, 2024 were 21.3M with a Short Ratio of 21.30, compared to 22.78M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 20.87% and a Short% of Float of 23.77%.
Earnings Estimates
As of right now, 3 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.27 for the current quarter, with a high estimate of -$0.23 and a low estimate of -$0.32, while EPS last year was -$0.36. The consensus estimate for the next quarter is -$0.25, with high estimates of -$0.19 and low estimates of -$0.32.
Analysts are recommending an EPS of between -$0.76 and -$1.31 for the fiscal current year, implying an average EPS of -$0.98. EPS for the following year is -$0.89, with 3 analysts recommending between -$0.53 and -$1.25.
Revenue Estimates
In the current quarter, 3 analysts expect revenue to total $11.36M. It ranges from a high estimate of $13M to a low estimate of $9.59M. As of the current estimate, Danimer Scientific Inc’s year-ago sales were $11.93M, an estimated decrease of -4.70% from the year-ago figure. For the next quarter, 3 analysts are estimating revenue of $13.92M, an increase of 0.10% over than the figure of -$4.70% in the same quarter last year. There is a high estimate of $16.1M for the next quarter, whereas the lowest estimate is $12.55M.
A total of 5 analysts have provided revenue estimates for DNMR’s current fiscal year. The highest revenue estimate was $113M, while the lowest revenue estimate was $63.13M, resulting in an average revenue estimate of $82.05M. In the same quarter a year ago, actual revenue was $46.68M, up 75.80% from the average estimate. Based on 5 analysts’ estimates, the company’s revenue will be $138.98M in the next fiscal year. The high estimate is $156.7M and the low estimate is $114.2M. The average revenue growth estimate for next year is up 69.40% from the average revenue estimate for this year.
